Study Recommending For Hepatitis C Virus Screening Tests

According to the study this is recommending for hepatitis C virus screening; this recommending screening for adults ages 18 to 79 is exactly; what is needing to address the dramatic increase in incidence of the disease. Hepatitis C virus screening is a casualty of the national opioid epidemic.

A majority of those who have it are substance users who share needles, many of whom are not aware that they are infected. The draft recommendation was issued today by the U.S. Preventive Services Task Force (USPSTF) an independent; volunteer panel of national experts in disease prevention that works to improve the health of Americans by making evidence based recommendations about clinical preventive services.

Virus Screening Tests

Previously, screening was recommending only for individuals at high risk and a one-time screening for baby boomers; those born between 1940 and 1965. This draft recommendation is a tremendous step forward in addressing the grim realities that we have been seeing over the past several years with hepatitis C virus screening. The purpose of the UB research is to find more effective ways to treat these individuals; who are at very high risk of developing HCV but are especially difficult to treat in conventional health care settings.

A third of all people who use drugs between the ages of 18 and 30 years are infecting with HCV; Between 2006 and 2014; HCV incidence doubled among women ages 15 to 44; and from 2011 to 2014, there were 68% more infants born to HCV-infected mothers. Talal is a physician with UBMD Internal Medicine, where he directs a liver disease specialty practice.

Integration of virtual management

However, the integration of virtual management of HCV treatment; with opioid treatment through telemedicine is seeing as a way to reach; and treat this vulnerable population. COMPA officials have noted that if the telemedicine approach proves successful with HCV; but they would be interesting in investigating how it might be using to treat other diseases this population experiences. Once a diagnosis is making and patients are linking to care; treatment results in a more than 95% cure rate after 8-12 weeks of treatment in most individuals, with minimal serious adverse events.

Viral elimination is associating with decreasing mortality; both from liver diseases and other causing and from cirrhosis and hepatocellular carcinoma. But this has encouraging many state governments; as well as the federal government, to set the elimination of HCV as a worthwhile and feasible goal. But talal noting that the new guidelines are a critical step toward fully addressing the HCV epidemic. The keys to eliminating HCV are boosting screening; increasing awareness among clinicians and patients, and finally, linking those diagnosed to care. The new recommendation is an extremely important step on that road